{"id":63248,"date":"2022-04-27T14:29:14","date_gmt":"2022-04-27T12:29:14","guid":{"rendered":"https:\/\/blog.cofb.cat\/?p=63248"},"modified":"2023-10-10T07:20:54","modified_gmt":"2023-10-10T07:20:54","slug":"farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/ca\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/","title":{"rendered":"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l’\u00fas d’antimicrobians"},"content":{"rendered":"\n

Els Programes d’Optimitzaci\u00f3 d’Antimicrobians (PROA)<\/strong> han significat una revoluci\u00f3 en l’\u00e0mbit assistencial<\/strong>, concretament, en la manera d’abordar l’\u00fas racional <\/strong>d’aquests f\u00e0rmacs. Aquest ha estat el tema central del cicle formatiu \u201cEls matins PROA\u201d<\/strong>, organitzat recentment pel Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB)<\/strong>, juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica (SCFC)<\/strong>, amb l’objectiu de donar m\u00e9s eines als farmac\u00e8utics\/es de l’\u00e0mbit hospitalari<\/strong> per familiaritzar-se amb els programes PROA, con\u00e8ixer les diferents estrat\u00e8gies<\/strong> per millorar l’administraci\u00f3 dels antimicrobians<\/strong>, fer un \u00fas correcte d’aquests en situacions especials<\/strong> i con\u00e8ixer el maneig de les interaccions farmacol\u00f2giques amb altres medicaments concomitants<\/strong>. <\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

La formaci\u00f3, que ha comptat amb el patrocini de Menarini<\/a><\/strong>, va estar coordinada pel vocal d’Hospitals del COFB, David Conde Est\u00e9vez<\/strong>, i la presidenta de la SCFC, Edurne Fern\u00e1ndez de Gamarra<\/strong>. Aquest cicle sobre PROA ja \u00e9s el segon any consecutiu que es realitza, consolidant-se com a trobada anual al voltant d’aquesta tem\u00e0tica. <\/strong>De fet, donat l’\u00e8xit <\/strong>de les dues edicions i la bona acceptaci\u00f3<\/strong> que t\u00e9 per part dels participants, les diferents entitats implicades en l’organitzaci\u00f3 continuaran treballant per a donar continu\u00eftat al projecte.<\/strong><\/p>\n\n\n\n

Estrat\u00e8gies per optimitzar l’\u00fas d’antimicrobians<\/strong><\/h2>\n\n\n\n

Al llarg de quatre sessions virtuals<\/strong>, els ponents van debatre diferents estrat\u00e8gies per optimitzar l’\u00fas d’antimicrobians<\/strong>, tot aix\u00f2 acompanyat amb un torn de debat-preguntes per promoure la reflexi\u00f3 conjunta entre docents i participants.<\/p>\n\n\n\n

Estrat\u00e8gia 1. Administracions especials, Tractament Antibi\u00f2tic Domiciliari Endoven\u00f3s (TADE)<\/strong><\/h3>\n\n\n\n

La primera sessi\u00f3, titulada \u201cAdministracions especials, Tractament Antibi\u00f2tic Domiciliari Endoven\u00f3s (TADE)\u201d<\/strong>, va estar impartida per Sara Ortonobes Roig<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia del Consorci Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed de Sabadell i moderada per la presidenta de la Societat Catalana de Farm\u00e0cia Cl\u00ednica, Edurne Fern\u00e1ndez de Gamarra<\/strong>. Durant la sessi\u00f3, i centrant-se en el TADE, Ortonobes va destacar la import\u00e0ncia del paper del Servei de Farm\u00e0cia en el circuit establert al seu hospital i va remarcar la integraci\u00f3 dels farmac\u00e8utics cl\u00ednics<\/strong> en l’equip multidisciplinari <\/strong>per optimitzar l’efic\u00e0cia i la seguretat del TADE. <\/p>\n\n\n\n

\"Sara
Sara Ortonobes Roig<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia del Consorci Corporaci\u00f3 Sanit\u00e0ria Parc Taul\u00ed de Sabadell, durant la seva formaci\u00f3. <\/figcaption><\/figure>\n\n\n\n

En la seva intervenci\u00f3, tamb\u00e9 va descriure aspectes relacionats amb l’assessorament farmac\u00e8utic. Concretament, sobre el tractament antimicrobi\u00e0, aix\u00ed com conceptes farmacot\u00e9cnicos rellevants en la preparaci\u00f3 i administraci\u00f3 del TADE.<\/p>\n\n\n\n

Estrat\u00e8gia 2. Dosificaci\u00f3 d’antibi\u00f2tics en situacions especials (obesitat, pediatria, persones grans)<\/strong><\/h3>\n\n\n\n

En la segona sessi\u00f3, impartida per S\u00f2nia Luque<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia del Parc de Salut Mar, i moderada per Aurora Fern\u00e1ndez<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia de l’Hospital Maternoinfantil Vall d\u2019Hebron, es va abordar la dosificaci\u00f3 d’antimicrobians en situacions especials (geriatria, obesitat i pediatria)<\/strong> i es van resumir els principals canvis farmacocin\u00e8tics que poden presentar aquests grups poblacionals<\/strong>, que requereixen ajustar la posologia dels diferents f\u00e0rmacs per optimitzar l’efic\u00e0cia i reduir el risc d’aparici\u00f3 d’efectes adversos.<\/p>\n\n\n\n

\"S\u00f2nia
S\u00f2nia Luque<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia del Parc de Salut Mar, en un moment de la seva sessi\u00f3.<\/figcaption><\/figure>\n\n\n\n

Finalment, es va recalcar la necessitat de valorar cada pacient de manera individual<\/strong>, ja que \u00e9s habitual que un mateix pacient pugui presentar diferents tipus d’alteracions fisiopatol\u00f2giques a considerar a l’hora de seleccionar el r\u00e8gim posol\u00f2gic m\u00e9s adequat.<\/p>\n\n\n\n

Estrat\u00e8gia 3. Les interaccions f\u00e0rmacs\/aliments, medicina complement\u00e0ria i antimicrobians<\/strong><\/h3>\n\n\n\n

La tercera sessi\u00f3 va anar a c\u00e0rrec de Montse Tuset<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia de l’Hospital Cl\u00ednic de Barcelona, i va comptar amb la moderaci\u00f3 d’Aurora Fern\u00e1ndez<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia de l’Hospital Maternoinfantil Vall d\u2019Hebron. <\/p>\n\n\n\n

\"Montse
Montse Tuset<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia de l’Hospital Cl\u00ednic de Barcelona. <\/figcaption><\/figure>\n\n\n\n

En aquesta sessi\u00f3 es va abordar que algunes de les interaccions dels f\u00e0rmacs antimicrobians poden tenir conseq\u00fc\u00e8ncies cl\u00edniques<\/strong>, tant reducci\u00f3 de l’efic\u00e0cia com increment de la toxicitat. Per tant, cal tenir-les en compte i continuar treballant en aquest \u00e0mbit per garantir la seguretat dels pacients.<\/p>\n\n\n\n

Estrat\u00e8gia 4. La durada \u00f2ptima dels tractaments antimicrobians<\/strong><\/h3>\n\n\n\n

La quarta i \u00faltima sessi\u00f3 la va impartir Sara Cobo<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia de l’Hospital de Bellvitge i va estar moderada per David Conde Est\u00e9vez<\/strong>, vocal d’Hospitals del COFB. Segons es va desprendre de la sessi\u00f3, per establir una durada \u00f2ptima dels tractaments antibi\u00f2tics fa falta un enfocament individualitzat segons l’evoluci\u00f3 cl\u00ednica<\/strong>. <\/p>\n\n\n\n

\"Sara
Sara Cobo<\/strong>, farmac\u00e8utica adjunta del Servei de Farm\u00e0cia de l’Hospital de Bellvitge, durant la 4 sessi\u00f3 dels “Matins Proa”. <\/figcaption><\/figure>\n\n\n\n

L’evid\u00e8ncia disponible<\/strong> dona suport a l’\u00fas de durades curtes de tractament<\/strong> per determinades indicacions, i aix\u00ed ho recullen algunes de les \u00faltimes guies de pr\u00e0ctica cl\u00ednica<\/strong>. Aix\u00ed mateix, els farmac\u00e8utics participen en equips PROA que realitzen intervencions dirigides a optimitzar els tractaments antibi\u00f2tics i la seva durada des d’una perspectiva multidisciplin\u00e0ria<\/strong>.<\/p>\n\n\n\n

\n
<\/div>\n\n\n\n
<\/div>\n\n\n\n
\n

Activitat organitzada conjuntament amb:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

<\/p>\n\n\n\n

<\/p>\n\n\n\n

Amb el patrocini:<\/strong><\/p>\n\n\n\n

\"\"<\/a><\/figure>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Els Programes d’Optimitzaci\u00f3 d’Antimicrobians (PROA) han significat una revoluci\u00f3 en l’\u00e0mbit assistencial, concretament, en la manera d’abordar l’\u00fas racional d’aquests f\u00e0rmacs. Aquest ha estat el tema central del cicle formatiu \u201cEls matins PROA\u201d, organitzat recentment pel Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica […]<\/p>\n","protected":false},"author":1,"featured_media":67924,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[16,64,18,19,281,53,68,70,283],"class_list":["post-63248","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-alimentacio-i-nutricio","tag-atencio-farmaceutica","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-els-matins-proa","tag-farmaceutics","tag-farmacia","tag-formacio","tag-proa"],"yoast_head":"\nFarmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l'\u00fas d'antimicrobians - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"Els PROA han significat una revoluci\u00f3 en l'\u00e0mbit assistencial, concretament, en la manera d'abordar l'\u00fas racional d'aquests f\u00e0rmacs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l'\u00fas d'antimicrobians - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Els PROA han significat una revoluci\u00f3 en l'\u00e0mbit assistencial, concretament, en la manera d'abordar l'\u00fas racional d'aquests f\u00e0rmacs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-27T12:29:14+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-10T07:20:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"508\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l’\u00fas d’antimicrobians\",\"datePublished\":\"2022-04-27T12:29:14+00:00\",\"dateModified\":\"2023-10-10T07:20:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\"},\"wordCount\":916,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg\",\"keywords\":[\"Alimentaci\u00f3 i nutrici\u00f3\",\"Atenci\u00f3 farmac\u00e8utica\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"Els Matins PROA\",\"farmac\u00e8utics\",\"Farm\u00e0cia\",\"Formaci\u00f3\",\"PROA\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\",\"name\":\"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l'\u00fas d'antimicrobians - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg\",\"datePublished\":\"2022-04-27T12:29:14+00:00\",\"dateModified\":\"2023-10-10T07:20:54+00:00\",\"description\":\"Els PROA han significat una revoluci\u00f3 en l'\u00e0mbit assistencial, concretament, en la manera d'abordar l'\u00fas racional d'aquests f\u00e0rmacs.\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg\",\"width\":1024,\"height\":508},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l’\u00fas d’antimicrobians\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"ca\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l'\u00fas d'antimicrobians - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"Els PROA han significat una revoluci\u00f3 en l'\u00e0mbit assistencial, concretament, en la manera d'abordar l'\u00fas racional d'aquests f\u00e0rmacs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/","og_locale":"ca_ES","og_type":"article","og_title":"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l'\u00fas d'antimicrobians - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"Els PROA han significat una revoluci\u00f3 en l'\u00e0mbit assistencial, concretament, en la manera d'abordar l'\u00fas racional d'aquests f\u00e0rmacs.","og_url":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2022-04-27T12:29:14+00:00","article_modified_time":"2023-10-10T07:20:54+00:00","og_image":[{"width":1024,"height":508,"url":"https:\/\/novaorg.cofb.net\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg","type":"image\/jpeg"}],"author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrit per":"wpAdminCofbOrg","Temps estimat de lectura":"5 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l’\u00fas d’antimicrobians","datePublished":"2022-04-27T12:29:14+00:00","dateModified":"2023-10-10T07:20:54+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/"},"wordCount":916,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg","keywords":["Alimentaci\u00f3 i nutrici\u00f3","Atenci\u00f3 farmac\u00e8utica","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","Els Matins PROA","farmac\u00e8utics","Farm\u00e0cia","Formaci\u00f3","PROA"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/","url":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/","name":"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l'\u00fas d'antimicrobians - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg","datePublished":"2022-04-27T12:29:14+00:00","dateModified":"2023-10-10T07:20:54+00:00","description":"Els PROA han significat una revoluci\u00f3 en l'\u00e0mbit assistencial, concretament, en la manera d'abordar l'\u00fas racional d'aquests f\u00e0rmacs.","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg","width":1024,"height":508},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2022\/04\/27\/farmaceutiques-i-farmaceutics-hospitalaris-es-formen-sobre-les-diferents-estrategies-a-seguir-per-optimitzar-lus-dantimicrobians\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Farmac\u00e8utiques i farmac\u00e8utics hospitalaris es formen sobre les diferents estrat\u00e8gies a seguir per optimitzar l’\u00fas d’antimicrobians"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"ca"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg",1024,508,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1-300x149.jpg",300,149,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1-768x381.jpg",768,381,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg",1024,508,false],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg",1024,508,false],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg",1024,508,false],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/07\/COFB_Matins-Proa_032022_5-1024x508-1.jpg",18,9,false]},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/ca\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"Els Programes d’Optimitzaci\u00f3 d’Antimicrobians (PROA) han significat una revoluci\u00f3 en l’\u00e0mbit assistencial, concretament, en la manera d’abordar l’\u00fas racional d’aquests f\u00e0rmacs. Aquest ha estat el tema central del cicle formatiu \u201cEls matins PROA\u201d, organitzat recentment pel Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB), juntament amb la Societat Catalana de Farm\u00e0cia Cl\u00ednica […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63248","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/comments?post=63248"}],"version-history":[{"count":3,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63248\/revisions"}],"predecessor-version":[{"id":69050,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/posts\/63248\/revisions\/69050"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media\/67924"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/media?parent=63248"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/categories?post=63248"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/ca\/wp-json\/wp\/v2\/tags?post=63248"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}